Cargando…
A functional genomics screen reveals a strong synergistic effect between docetaxel and the mitotic gene DLGAP5 that is mediated by the androgen receptor
Based on a molecular classification of prostate cancer using gene expression pathway signatures, we derived a set of 48 genes in critical pathways that significantly predicts clinical outcome in all tested patient cohorts. We tested these genes in a functional genomics screen in a panel of three pro...
Autores principales: | Hewit, Kay, Sandilands, Emma, Martinez, Rafael Sanchez, James, Daniel, Leung, Hing Y., Bryant, David M., Shanks, Emma, Markert, Elke K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195526/ https://www.ncbi.nlm.nih.gov/pubmed/30341281 http://dx.doi.org/10.1038/s41419-018-1115-7 |
Ejemplares similares
-
Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment
por: Rushworth, Linda K., et al.
Publicado: (2019) -
Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration‐resistant prostate cancer
por: Pilling, Amanda, et al.
Publicado: (2021) -
Screening and identification of LMNB1 and DLGAP5, two key biomarkers in gliomas
por: Zhou, Ding, et al.
Publicado: (2021) -
An ARF GTPase module promoting invasion and metastasis through regulating phosphoinositide metabolism
por: Nacke, Marisa, et al.
Publicado: (2021) -
Identification and prognostic value of DLGAP5 in endometrial cancer
por: Zheng, Ruoyi, et al.
Publicado: (2020)